These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

307 related items for PubMed ID: 20053895

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Restoration of SMN function: delivery of a trans-splicing RNA re-directs SMN2 pre-mRNA splicing.
    Coady TH, Shababi M, Tullis GE, Lorson CL.
    Mol Ther; 2007 Aug; 15(8):1471-8. PubMed ID: 17551501
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Genomic Variability in the Survival Motor Neuron Genes (SMN1 and SMN2): Implications for Spinal Muscular Atrophy Phenotype and Therapeutics Development.
    Butchbach MER.
    Int J Mol Sci; 2021 Jul 23; 22(15):. PubMed ID: 34360669
    [Abstract] [Full Text] [Related]

  • 8. Delivery of bifunctional RNAs that target an intronic repressor and increase SMN levels in an animal model of spinal muscular atrophy.
    Baughan TD, Dickson A, Osman EY, Lorson CL.
    Hum Mol Genet; 2009 May 01; 18(9):1600-11. PubMed ID: 19228773
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Improved antisense oligonucleotide design to suppress aberrant SMN2 gene transcript processing: towards a treatment for spinal muscular atrophy.
    Mitrpant C, Porensky P, Zhou H, Price L, Muntoni F, Fletcher S, Wilton SD, Burghes AH.
    PLoS One; 2013 May 01; 8(4):e62114. PubMed ID: 23630626
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. 5-(N-ethyl-N-isopropyl)-amiloride enhances SMN2 exon 7 inclusion and protein expression in spinal muscular atrophy cells.
    Yuo CY, Lin HH, Chang YS, Yang WK, Chang JG.
    Ann Neurol; 2008 Jan 01; 63(1):26-34. PubMed ID: 17924536
    [Abstract] [Full Text] [Related]

  • 16. Therapeutics development for spinal muscular atrophy.
    Sumner CJ.
    NeuroRx; 2006 Apr 01; 3(2):235-45. PubMed ID: 16554261
    [Abstract] [Full Text] [Related]

  • 17. Combined treatment with the histone deacetylase inhibitor LBH589 and a splice-switch antisense oligonucleotide enhances SMN2 splicing and SMN expression in Spinal Muscular Atrophy cells.
    Pagliarini V, Guerra M, Di Rosa V, Compagnucci C, Sette C.
    J Neurochem; 2020 Apr 01; 153(2):264-275. PubMed ID: 31811660
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Heat increases full-length SMN splicing: promise for splice-augmenting therapies for SMA.
    Dominguez CE, Cunningham D, Venkataramany AS, Chandler DS.
    Hum Genet; 2022 Feb 01; 141(2):239-256. PubMed ID: 35088120
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.